Insider and congress filings

Medtronic Plc (MDT)

NYSE · Healthcare · 356 insider transactions · 177 congress trades · last filed 5 days agoS&P 500

5
Open-market insider filings shown
1d
Median delay on the insider filings, in business days
within the two business day rule
0 buys·5 sells
Purchases and sales in the filings shown
Get a push when an insider at Medtronic Plc trades.

Free on iOS and Android.

About Medtronic Plc

from the company's filings and listing, as of Oct 20, 2026
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Devices
Chief executive
Geoffrey Straub Martha
Employees
95,000
Listed since
-
Market value
$118.7B
Price to earnings (12 mo)
22.7
Net income per share, as reported (12 mo)
$4.09
Dividend yield
3.08%

www.medtronic.com

Company news

1 article · newest first
HeadlineSourceDate
Medtronic presents registry results for Sphere-9 and PulseSelect at APHRS 2026The global analyses cover patients with atrial fibrillation and ventricular tachycardia, and Medtronic said the results were positive.Company releaseOct 22, 2026

Written by GetSignal with AI from the company's own SEC filings and press releases; each article links to its source. Not investment advice. Company news from every company we cover

Earnings

6 reported quarters · next on Nov 17, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q1 FY2027reported Sep 1, 2026$1.45$1.39$9.8B$9.5BEPS beatRevenue beat
Q4 FY2026reported Jun 3, 2026$1.55$1.54$9.8B$9.6BEPS in lineRevenue beat
Q3 FY2026reported Feb 17, 2026$1.36$1.34$9.0B$8.9BEPS in lineRevenue in line
Q2 FY2026reported Nov 18, 2025$1.36$1.31$9.0B$8.9BEPS beatRevenue in line
Q1 FY2026reported Aug 19, 2025$1.26$1.23$8.6B$8.4BEPS beatRevenue beat
Q4 FY2025reported May 21, 2025$1.62$1.58$8.9B$8.8BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2026 · proxy filed Aug 17, 2026
ExecutiveSalaryStock awardsOtherTotal
Geoff MarthaChairman and Chief Executive Officer$1.4M$13.7M$7.9M$22.9M
Thierry PiétonEVP, Chief Financial Officer$850K$3.2M$4.6M$8.6M
Mike MarinaroEVP & President Medical Surgical Portfolio & Americas$820K$3.6M$2.4M$6.8M
Michelle QuinnEVP, General Counsel and Secretary$600K$3.5M$2.6M$6.7M

The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$8.9B114,020,787+0.7%8.91%
Vanguard Capital Management LLC$6.6B83,816,735+0.6%6.55%
State Street Corp$5.0B63,399,315+2.7%4.95%
Vanguard Portfolio Management LLC$2.7B34,059,967+1.8%2.66%
Massachusetts Financial Services Co$2.6B19,872,600-7.3%1.55%
Geode Capital Management, LLC$2.4B30,192,015+5.1%2.36%
JPMorgan Chase & Co.$2.2B27,784,471-45.5%2.17%
Bank of America Corp$1.7B21,322,401-18.0%1.67%
Morgan Stanley$1.5B19,444,871-6.1%1.52%
Deutsche Bank AG$1.4B18,449,877-2.9%1.44%
Invesco Ltd.$1.4B17,885,150+6.5%1.40%
Franklin Templeton Inc$1.4B17,550,983+23.8%1.37%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Tracked fund managers holding MDT

2 managers
ManagerValueSharesShare of book
Renaissance TechnologiesJim Simons$247.8M3,167,7410.3%
Trexquant Investment$88.6M1,132,7410.5%

2 of the 97 fund managers we track list MDT shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.

Know when the next MDT filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

5 filings shown · newest filing first
InsiderActionSharesPriceValueTrade dateDelay
(business days)
Geoffrey MarthaChairman and CEOSold · scheduled50,000$95.00$4.8MOct 15, 2026filed Oct 16, 20261d
Michael MarinaroEVP, Pres Medsurg and AmericasSold · scheduled10,420$96.00$1.0MOct 15, 2026filed Oct 16, 20261d
Harry Skip KiilEVP & President CardiovascularSold1,483$93.65$139KSep 16, 2026filed Sep 17, 20261d
Matthew R. WalterSVP, Chief HR OfficerSold · scheduled3,102$83.15$258KJul 8, 2026filed Jul 9, 20261d
Harry Skip KiilEVP & President CardiovascularSold · 2 lines4,189$80.44$337KJun 8, 2026filed Jun 9, 20261d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (20)
InsiderEventSharesDate
Kevin E. LoftonDirectorOther (see filing)182Oct 15, 2026
Denise L. BlomquistChief Accounting OfficerGift600Sep 15, 2026
Michael MarinaroEVP, Pres Medsurg and AmericasTax withholding1,084Aug 20, 2026
Matthew R. WalterSVP, Chief HR OfficerStock award61,163Aug 3, 2026
Matthew R. WalterSVP, Chief HR OfficerTax withholding1,675Jul 31, 2026
Denise L. BlomquistChief Accounting OfficerStock award3,703Aug 3, 2026
Denise L. BlomquistChief Accounting OfficerTax withholding212Jul 31, 2026
Geoffrey MarthaChairman and CEOStock award713,516Aug 3, 2026
Geoffrey MarthaChairman and CEOTax withholding15,810Jul 31, 2026
Harry Skip KiilEVP & President CardiovascularStock award97,860Aug 3, 2026
Harry Skip KiilEVP & President CardiovascularTax withholding3,074Jul 31, 2026
Michael MarinaroEVP, Pres Medsurg and AmericasStock award162,355Aug 3, 2026
Michael MarinaroEVP, Pres Medsurg and AmericasTax withholding3,356Jul 31, 2026
Thierry PietonEVP & Chief Financial OfficerStock award122,324Aug 3, 2026
Michelle QuinnEVP, GC and SecretaryStock award67,279Aug 3, 2026
Kweli ThompsonEVP & President, NeuroscienceStock award73,396Aug 3, 2026
Kweli ThompsonEVP & President, NeuroscienceTax withholding1,739Jul 31, 2026
Michelle QuinnEVP, GC and SecretaryTax withholding2,069Jul 28, 2026
Kweli ThompsonEVP & President, NeuroscienceOther Form 4 entry (see filing)22,363Jul 28, 2026
Kweli ThompsonEVP & President, NeuroscienceOther Form 4 entry (see filing)1,540Jul 29, 2025

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Congress trades in MDT

20 disclosures of 177 on record · median 25d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Kevin HernJointStockSale$15,001 - $50,000+2.7%After the saleS&P 500 -0.5% · +3.2 pts vs S&P 500Aug 24, 2026Sep 1, 20268d
Richard McCormickStockSale$1,001 - $15,000+11.3%After the saleS&P 500 +2.5% · +8.9 pts vs S&P 500Jul 30, 2026Aug 14, 202615d
Julie JohnsonJointFiled lateStockSale$1,001 - $15,000+14.7%After the saleS&P 500 +35.4% · -20.7 pts vs S&P 500May 7, 2025Aug 5, 2026455d
Alan ArmstrongSelfStockPurchase$1,001 - $15,000+9.5%S&P 500 +19.8% · -10.3 pts vs S&P 500Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockPurchase$1,001 - $15,000+25.3%S&P 500 +2.8% · +22.5 pts vs S&P 500May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+25.6%S&P 500 +1.3% · +24.3 pts vs S&P 500May 27, 2026Jun 9, 202613d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+25.3%After the saleS&P 500 +2.8% · +22.5 pts vs S&P 500May 15, 2026Jun 8, 202624d
Ro KhannaStockSale$15,001 - $50,000+6.1%After the saleS&P 500 +12.2% · -6.0 pts vs S&P 500Mar 10, 2026Apr 7, 202628d
Ro KhannaStockSale$1,001 - $15,000+9.5%After the saleS&P 500 +15.6% · -6.1 pts vs S&P 500Mar 23, 2026Apr 7, 202615d
Ro KhannaStockSale$1,001 - $15,000+11.3%After the saleS&P 500 +20.3% · -9.0 pts vs S&P 500Mar 30, 2026Apr 7, 20268d
Kevin HernJointStockSale$15,001 - $50,000+10.7%After the saleS&P 500 +16.8% · -6.1 pts vs S&P 500Mar 20, 2026Apr 3, 202614d
Ro KhannaStockPurchase$1,001 - $15,000-5.4%S&P 500 +10.2% · -15.6 pts vs S&P 500Jan 23, 2026Feb 6, 202614d
Ro KhannaStockSale$1,001 - $15,000-5.8%After the saleS&P 500 +10.3% · -16.1 pts vs S&P 500Jan 22, 2026Feb 6, 202615d
Julie JohnsonJointStockSale$1,001 - $15,000-3.1%After the saleS&P 500 +12.3% · -15.4 pts vs S&P 500Dec 18, 2025Jan 15, 202628d
Julie JohnsonJointStockSale$1,001 - $15,000-0.8%After the saleS&P 500 +13.0% · -13.8 pts vs S&P 500Nov 13, 2025Dec 11, 202528d
Richard McCormickStockPurchase$1,001 - $15,000+5.5%S&P 500 +12.2% · -6.6 pts vs S&P 500Nov 5, 2025Dec 9, 202534d
Richard McCormickStockPurchase$1,001 - $15,000+21.7%S&P 500 +95.3% · -73.6 pts vs S&P 500Mar 15, 2023Sep 17, 2025917d
Julie JohnsonJointStockSale$1,001 - $15,000+3.7%After the saleS&P 500 +17.8% · -14.1 pts vs S&P 500Aug 14, 2025Sep 11, 202528d
Ro KhannaStockPurchase$1,001 - $15,000+6.4%S&P 500 +20.4% · -14.0 pts vs S&P 500Aug 4, 2025Sep 9, 202536d
Ro KhannaStockSale$1,001 - $15,000+10.9%After the saleS&P 500 +23.2% · -12.3 pts vs S&P 500Jun 27, 2025Jul 9, 202512d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in MDT, filterable by party, chamber, type and account.

Members of Congress reporting a position

15 members · estimate, as of Oct 19, 2026

15 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Gary C. PetersDemocrat · Senate$15,001 - $50,0001.0%
Robert BresnahanRepublican · House$15,001 - $50,0000.2%
Debbie DingellDemocrat · House$15,001 - $50,0000.4%
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%
Harriet M. HagemanRepublican · House$15,001 - $50,0000.5%
Daniel MeuserRepublican · House$15,001 - $50,0000.6%
George WhitesidesDemocrat · House$1,001 - $15,0000.1%
Shelley Moore CapitoRepublican · Senate$1,001 - $15,0000.4%
Ron WydenDemocrat · Senate$1,001 - $15,0000.1%
Cliff BentzRepublican · House$1,001 - $15,0000.5%
Robert B. AderholtRepublican · House$1,001 - $15,0001.0%
James ComerRepublican · House$1,001 - $15,0001.7%
Lucy McBathDemocrat · House$1,001 - $15,0000.1%
Robert OnderRepublican · House$1,001 - $15,0000.2%
Richard McCormickRepublican · House$1,001 - $15,0002.2%

Estimate, as of Oct 19, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Are insiders buying or selling MDT?

Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales. 3 were scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded MDT?

Kevin Hern, Richard McCormick, Julie Johnson, Alan Armstrong, Ro Khanna and Gilbert Ray Cisneros, Jr. disclosed MDT transactions in the filings shown here.

Which members of Congress hold MDT?

15 members of Congress report a position in MDT in the estimate we hold as of Oct 19, 2026. The largest estimated positions, in the $15,001 - $50,000 band, include Gary C. Peters, Robert Bresnahan and Debbie Dingell. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is MDT in the S&P 500 or the Nasdaq 100?

Medtronic Plc is a current member of the S&P 500, per the membership list we hold as of Oct 26, 2026. Current members of either index get a page here whatever their filing history.

How quickly are MDT trades disclosed?

Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track